propranolol has been researched along with Cerebral Infarction, Middle Cerebral Artery in 6 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Stroke was induced in mice by middle cerebral artery occlusion for 90 minutes, followed by reperfusion." | 1.46 | Hepatic Ketogenesis Induced by Middle Cerebral Artery Occlusion in Mice. ( Berressem, D; Eckert, GP; Klein, J; Koch, K; Konietzka, J; Thinnes, A, 2017) |
| "Propranolol treatment also had no effects on these outcomes." | 1.35 | Blockade of adrenoreceptors inhibits the splenic response to stroke. ( Ajmo, CT; Collier, LA; Cuevas, J; Green, SM; Hall, AA; Leonardo, CC; Pennypacker, KR; Willing, AE; Womble, TA, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koch, K | 1 |
| Berressem, D | 1 |
| Konietzka, J | 1 |
| Thinnes, A | 1 |
| Eckert, GP | 1 |
| Klein, J | 1 |
| Wang, H | 1 |
| Deng, QW | 1 |
| Peng, AN | 1 |
| Xing, FL | 1 |
| Zuo, L | 1 |
| Li, S | 1 |
| Gu, ZT | 1 |
| Yan, FL | 2 |
| Zhang, JH | 1 |
| Ajmo, CT | 1 |
| Collier, LA | 1 |
| Leonardo, CC | 1 |
| Hall, AA | 1 |
| Green, SM | 1 |
| Womble, TA | 1 |
| Cuevas, J | 1 |
| Willing, AE | 1 |
| Pennypacker, KR | 1 |
| Lodha, A | 1 |
| Haran, M | 1 |
| Frankel, R | 1 |
| Shani, J | 1 |
| Wong, CH | 1 |
| Jenne, CN | 1 |
| Lee, WY | 1 |
| Léger, C | 1 |
| Kubes, P | 1 |
6 other studies available for propranolol and Cerebral Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Hepatic Ketogenesis Induced by Middle Cerebral Artery Occlusion in Mice.
Topics: 3-Hydroxybutyric Acid; Adrenergic beta-Antagonists; Animals; Brain; Brain Ischemia; Citric Acid; Die | 2017 |
β-arrestin2 functions as a key regulator in the sympathetic-triggered immunodepression after stroke.
Topics: Animals; beta-Arrestin 2; Brain Infarction; Cell Line, Transformed; Cytokines; Disease Models, Anima | 2018 |
Role of the sympathetic nervous system and spleen in experimental stroke-induced immunodepression.
Topics: Animals; Brain Infarction; Immunosuppression Therapy; Infarction, Middle Cerebral Artery; Injections | 2014 |
Blockade of adrenoreceptors inhibits the splenic response to stroke.
Topics: Adrenergic alpha-Antagonists; Adrenergic Antagonists; Adrenergic beta-Antagonists; Animals; Carbazol | 2009 |
Thyrotoxicosis causing arterial and venous thrombosis.
Topics: Anticoagulants; Antithyroid Agents; Blood Coagulation; Humans; Infarction, Middle Cerebral Artery; M | 2009 |
Functional innervation of hepatic iNKT cells is immunosuppressive following stroke.
Topics: Adrenergic Agents; Animals; Anti-Bacterial Agents; Bacterial Infections; Brain Ischemia; Cell Moveme | 2011 |